Trade Info : CapitalNumbers Infotech wins a 2.46 crore AI project for healthcare.

Symbol

544343

Company

CapitalNumbers Infotech Ltd

Category

New Order

Source

Stock Exchange Filing

Order Value

2.46 Crore

Project Duration

6 Months

Contract Type

Time and Materials

News Summary

CapitalNumbers Infotech Limited secured a new contract worth 2.46 crore rupees on June 11, 2026.
The project involves artificial intelligence work specifically for the healthcare industry.
The client is an international company based in the United Kingdom.

Why This Matters

This new income shows the company is successfully finding work outside India.
International contracts often bring higher pay and better growth for the business.
Investors should see this as a sign that demand for their tech skills is rising.

Fundamental Backdrop (FY – FY )

Metric	Value
Order Value	2.46 Crore Rupees
Project Duration	6 Months
Contract Type	Time and Materials
Client Location	United Kingdom

Analyst's View

The company appears to be expanding its global reach quickly.
This suggests the business is adapting well to international needs.
Investors may want to watch how much of this project gets finished on time.
Success here could lead to even bigger orders from other countries soon.

Buy

Confidence 75%

Conviction Level 75%

The company is securing valuable international work that boosts future earnings potential.

Key Positives

A new 2.46 crore rupee order adds direct revenue to the books.
The project uses advanced AI technology which is a high-growth field.
Working with a UK client shows strong global trust in the company.

Key Risks

The client name is hidden, so we do not know their full reputation.
International projects can face delays due to different time zones or rules.
The contract is short term at six months which may not guarantee steady future work.

HorizonMedium term

Confidence LevelMedium

Suggested position size: Moderate allocation suitable for growth portfolios with some global exposure.

⚠️

Disclaimer This analysis is for informational purposes only and does not constitute financial advice. Do your own research and consult a qualified financial professional before making any investment decisions.